(Q46022439)

18 December 2017

title

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients. (English)

1 reference

18 December 2017

1 reference

1 reference

Kemp J

1

1 reference

18 December 2017

Wolfe J

2

1 reference

18 December 2017

Grady J

3

1 reference

18 December 2017

LaForce C

4

1 reference

18 December 2017

Stahl E

5

1 reference

18 December 2017

Arledge T

6

1 reference

18 December 2017

Liddle R

7

1 reference

18 December 2017

publication date

1 March 1998

1 reference

18 December 2017

published in

Clinical Therapeutics

1 reference

18 December 2017

volume

20

1 reference

18 December 2017

page(s)

270-282

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Salmeterol does not cause tolerance during long-term asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Standardization of spirometry: a summary of recommendations from the American Thoracic Society. The 1987 update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Twelve months, treatment with inhaled salmeterol in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Exacerbations of asthma in patients on salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

Asthma exacerbations in patients taking regular salmeterol, or salbutamol for symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980090-8

7 January 2021

10.1016/S0149-2918(98)80090-8

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

9589818

1 reference

18 December 2017